Welcome to LookChem.com Sign In|Join Free
  • or
(8-BOC-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-2-YL)-ACETIC ACID METHYL ESTER is a heterocyclic chemical compound with the molecular formula C20H27NO3. It is a methyl ester derivative of the carboxylic acid (8-BOC-5,6,7,8-Tetrahydro-[1,8]naphthyridin-2-yl)-acetic acid. (8-BOC-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-2-YL)-ACETIC ACID METHYL ESTER is characterized by its cyclic structure and the presence of a BOC (tert-butyloxycarbonyl) protecting group, which enhances its stability and pharmacokinetic properties. It has potential antineoplastic and immunomodulating activities, making it a promising candidate in medicinal chemistry research and drug development.

925889-81-2

Post Buying Request

925889-81-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

925889-81-2 Usage

Uses

Used in Pharmaceutical Industry:
(8-BOC-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-2-YL)-ACETIC ACID METHYL ESTER is used as a pharmaceutical intermediate for the development of drugs with potential antineoplastic and immunomodulating properties. Its unique structure and the presence of the BOC protecting group contribute to its potential therapeutic applications in the treatment of cancer and autoimmune diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (8-BOC-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-2-YL)-ACETIC ACID METHYL ESTER serves as a valuable compound for studying its chemical properties, synthesis, and potential interactions with biological targets. Researchers can use (8-BOC-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-2-YL)-ACETIC ACID METHYL ESTER to explore new drug candidates and optimize their pharmacological profiles for improved efficacy and safety.
Used in Drug Development:
(8-BOC-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-2-YL)-ACETIC ACID METHYL ESTER is utilized in drug development processes to create novel therapeutic agents. Its potential antineoplastic and immunomodulating activities make it a promising candidate for the development of drugs targeting cancer and autoimmune diseases. (8-BOC-5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-2-YL)-ACETIC ACID METHYL ESTER's stability and pharmacokinetic properties, enhanced by the BOC protecting group, facilitate its progression through the drug development pipeline.

Check Digit Verification of cas no

The CAS Registry Mumber 925889-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,8,8 and 9 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 925889-81:
(8*9)+(7*2)+(6*5)+(5*8)+(4*8)+(3*9)+(2*8)+(1*1)=232
232 % 10 = 2
So 925889-81-2 is a valid CAS Registry Number.
InChI:InChI=1/C16H22N2O4/c1-16(2,3)22-15(20)18-9-5-6-11-7-8-12(17-14(11)18)10-13(19)21-4/h7-8H,5-6,9-10H2,1-4H3

925889-81-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 7-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxylate

1.2 Other means of identification

Product number -
Other names (8-boc-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-acetic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:925889-81-2 SDS

925889-81-2Relevant academic research and scientific papers

Pyrrolidine integrin regulator and application thereof

-

, (2021/09/08)

Disclosed are a compound as represented by formula I, and a racemate, a stereoisomer, a tautomer, an isotopic marker, a nitrogen oxide, a solvate, a polymorph, a metabolite, an ester, and a prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and the medical use thereof. The structure of formula I is as follows:

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 925889-81-2